[TNGX] QoQ Quarter Result on 30-Sep-2020 [#Q3]

Stock
[TNGX] Tango Therapeutics, Inc.
Announcement Date
13-Nov-2020
Financial Year
2020
Quarter
30-Sep-2020 [#Q3]
Profit Trend
QoQ- -219.38%
YoY-
Quarter Report
TNGX's Result
TNGX's Financial Summary
View:
Show?
Quarter Result
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
Revenue 6,787 18,153 6,386 9,142 -11,261 5,064 4,711 27.53%
PBT -19,528 -4,514 -12,032 -8,864 -26,802 -8,392 -7,914 82.50%
Tax 62 -21 74 0 50 0 0 -
NP -19,590 -4,493 -12,106 -8,864 -26,802 -8,392 -7,914 82.88%
Tax Rate - - - - - - - -
Total Cost 26,377 22,646 18,492 18,006 15,541 13,456 12,625 63.35%
Ratio Analysis
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
NP Margin -288.64 -24.75 -189.57 -96.96 238.01 -165.72 -167.99 43.40%
Per Share
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
EPS -0.28 -0.05 -0.14 -0.53 -0.31 -0.75 -0.74 -47.65%
EPS Diluted -0.28 -0.05 -0.14 -0.42 -0.31 -0.75 -0.74 -47.65%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.